Quality assurance in Italy 2017

Italy Country Drug Report 2017

Quality assurance

The Italian National Action Plan on Drugs 2010-13 reiterates that drug treatment and other interventions should be continually assessed through systematic evaluation of their safety, efficacy, acceptability, ethics, financial sustainability and the degree of customer satisfaction. In general, the monitoring and continuous evaluation of effects of interventions should be based on rigorous evaluations; however, apart from some scientific projects conducted in recent years, no systematic evaluations of the interventions that are implemented in Italy are available.

The Italian Department of the National Antidrug Policies (DPA) has undertaken several training activities; the most recent activity had the aim of enhancing the knowledge of policymakers on how to apply the International Standards on Drug Use Prevention that were issued by the United Nations Office on Drugs and Crime in planning prevention interventions at the national level.

The DPA collects information on quality assurance from all the regions and the autonomous provinces through a structured questionnaire that is issued by the EMCDDA.

In Italy, health services are accredited through the National Health System, which is delegated to the individual regions/autonomous provinces; services for drug users are part of this system. Regions and autonomous provinces increasingly assess the drug treatment quality using guidelines. A number of Italian prevention centres are supporting and implementing the European Drug Prevention Quality Standards, Phase II.

Only a few regions have reported the implementation of continuing education courses for psychologists.

In Italy, health services are accredited through the National Health System, which is delegated to the individual regions/ autonomous provinces; services for drug users are part of this system


Italy main page
Loading